|
1
|
Des Guetz G, Uzzan B, Bouillet T, et al:
Impact of physical activity on cancer-specific and overall survival
of patients with colorectal cancer. Gastroenterol Res Pract.
2013:3408512013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Søgaard M, Thomsen RW, Bossen KS, Sørensen
HT and Nørgaard M: The impact of comorbidity on cancer survival: a
review. Clin Epidemiol. 5(Suppl 1): 3–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiu BC, Ji BT, Dai Q, Gridley G,
McLaughlin JK, Gao YT, Fraumeni JF Jr and Chow WH: Dietary factors
and risk of colon cancer in Shanghai, China. Cancer Epidemiol
Biomarkers Prev. 12:201–208. 2003.PubMed/NCBI
|
|
4
|
Walker AS, Zwintscher NP, Johnson EK,
Maykel JA, Stojadinovic A, Nissan A, Avital I, Brücher BL and
Steele SR: Future directions for monitoring treatment response in
colorectal cancer. J Cancer. 5:44–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu
K, Yu J and Sung JJ: MicroRNA in colorectal cancer: from benchtop
to bedside. Carcinogenesis. 32:247–253. 2011. View Article : Google Scholar
|
|
8
|
Kjaer-Frifeldt S, Hansen TF, Nielsen BS,
Joergensen S, Lindebjerg J, Soerensen FB, dePont Christensen R and
Jakobsen A: The prognostic importance of miR-21 in stage II colon
cancer: a population-based study. Br J Cancer. 107:1169–1174. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu W, Yang J, Feng X, Wang H, Ye S, Yang
P, Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates
phosphatase and tensin homologue (PTEN) expression and promotes
growth, migration, and invasion in colorectal carcinoma cells. Mol
Cancer. 12:302013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan K, Xie K, Fox J, Zeng H, Gao H, Huang
C and Wu M: Decreased levels of miR-224 and the passenger strand of
miR-221 increase MBD2, suppressing maspin and promoting colorectal
tumor growth and metastasis in mice. Gastroenterology. 145:853–864.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, et al: MicroRNA expression profiles associated with prognosis
and therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haegebarth A and Clevers H: Wnt signaling,
lgr5, and stem cells in the intestine and skin. Am J Pathol.
174:715–721. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wilson C: Diabetes: Human β-cell
proliferation by promoting Wnt signalling. Nat Rev Endocrinol.
9:5022013. View Article : Google Scholar
|
|
14
|
Huang J, Gao K, Lin J and Wang Q:
MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting
Cyr61. Tumour Biol. 35:1095–1100. 2014. View Article : Google Scholar
|
|
15
|
Zheng YS, Zhang H, Zhang XJ, Feng DD, et
al: MiR-100 regulates cell differentiation and survival by
targeting RBSP3, a phosphatase-like tumor suppressor in acute
myeloid leukemia. Oncogene. 31:80–92. 2012. View Article : Google Scholar :
|
|
16
|
Chen P, Zhao X and Ma L: Downregulation of
microRNA-100 correlates with tumor progression and poor prognosis
in hepatocellular carcinoma. Mol Cell Biochem. 383:49–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Lu KH, Liu ZL, Sun M, De W and Wang
ZX: MicroRNA-100 is a potential molecular marker of non-small cell
lung cancer and functions as a tumor suppressor by targeting
polo-like kinase 1. BMC Cancer. 12:5192012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gebeshuber CA and Martinez J: miR-100
suppresses IGF2 and inhibits breast tumorigenesis by interfering
with proliferation and survival signaling. Oncogene. 32:3306–3310.
2013. View Article : Google Scholar
|
|
19
|
Leushacke M and Barker N: Lgr5 and Lgr6 as
markers to study adult stem cell roles in self-renewal and cancer.
Oncogene. 31:3009–3022. 2012. View Article : Google Scholar
|
|
20
|
Fukuma M, Tanese K, Effendi K, Yamazaki K,
Masugi Y, Suda M and Sakamoto M: Leucine-rich repeat-containing G
protein-coupled receptor 5 regulates epithelial cell phenotype and
survival of hepatocellular carcinoma cells. Exp Cell Res.
319:113–121. 2013. View Article : Google Scholar
|
|
21
|
Zeki SS, Graham TA and Wright NA: Stem
cells and their implications for colorectal cancer. Nat Rev
Gastroenterol Hepatol. 8:90–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schuijers J and Clevers H: Adult mammalian
stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J.
31:2685–2696. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis A, Segditsas S, Deheragoda M, et al:
Severe polyposis in Apc(1322T) mice is associated with submaximal
Wnt signalling and increased expression of the stem cell marker
Lgr5. Gut. 59:1680–1686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Dai W, Jiang L and Cheng Y:
Over-expression of LGR5 correlates with poor survival of colon
cancer in mice as well as in patients. Neoplasma. 61:177–185. 2014.
View Article : Google Scholar
|
